Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inhibitory Effects of Lansoprazole and Omeprazole on the CYP2C19-Mediated Metabolism of Arachidonic Acid to Epoxyeicosatrienoic Acids: Implications for Cardiovascular Risk.

Biological & pharmaceutical bulletin·2026
Same author

Three-Dimensional CH/π and CH/N Interactions from Quantum-Mechanical and Database Analyses.

Journal of chemical information and modeling·2025
Same author

Molecular Interaction Fields Describing Halogen Bond Formable Areas on Protein Surfaces.

Journal of chemical information and modeling·2024
Same author

Design, synthesis, structure-activity relationship studies, and evaluation of novel GLS1 inhibitors.

Bioorganic & medicinal chemistry letters·2023
Same author

The Stat3 inhibitor F0648-0027 is a potential therapeutic against rheumatoid arthritis.

Biochemical and biophysical research communications·2022
Same author

Discovery of novel orexin receptor antagonists using a 1,3,5-trioxazatriquinane bearing multiple effective residues (TriMER) library.

European journal of medicinal chemistry·2022
Same journal

[Autophagy in embryogenesis and cell differentiation].

Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme·2010
Same journal

[Membrane traffic: Overview].

Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme·2010
Same journal

[Oncogenic HMGA1a protein causes sporadic Alzheimer's disease-associated aberrant splicing].

Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme·2010
Same journal

[Aberrant pre-mRNA splicing in neurological disorders].

Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme·2010
Same journal

[Autoimmune diseases and RNA].

Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme·2010
Same journal

[Self or non-self RNA sensing mechanism of innate antiviral immunity].

Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme·2010
See all related articles

Related Experiment Video

Updated: Jun 6, 2026

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

[Practical in silico structure-based drug design]

Shuichi Hirono1, Hiroaki Gouda

  • 1hironos@pharm.kitasato-u.ac.jp

Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme
|November 25, 2010
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

Related Experiment Videos

Last Updated: Jun 6, 2026

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025